Hongxing (Harry) Zhou is the founder of Proviva Therapeutics. Proviva Therapeutics has raised $13M in total funding. Latest round: Series A.
Hongxing (Harry) Zhou is the Co-Founder & CEO of Proviva Therapeutics, a role he has held since May 2019. His location is listed inconsistently across sources, with LinkedIn placing him in Greater Boston, United States, and PitchBook in Shanghai, China.
Full founder directory · Investor directory · Company funding database · Fundraising library